Giovannoni G, et al. Treatment outcomes of daclizumab in patients at high risk of transitioning to secondary progressive multiple sclerosis in DECIDE. EAN 2107, O2113.
Armzwaai is potentiële prodromale marker voor Parkinson
mei 2017 | Bewegingsstoornissen